Mycoplasma pneumoniae and Chlamydia spp. Infection in Community-Acquired Pneumonia, Germany, 2011–2012
Roger Dumke, Christiane Schnee, Mathias W. Pletz, Jan Rupp, Enno Jacobs, Konrad Sachse1
, Gernot Rohde1
, and CAPNETZ Study Group2
Author affiliations: Technical University Dresden Institute of Medical Microbiology and Hygiene, Dresden, Germany (R. Dumke, E. Jacobs); Friedrich-Loeffler-Institut, Jena, Germany (C. Schnee, K. Sachse); Jena University Hospital Center for Infectious Diseases and Infection Control, Jena (M.W. Pletz); CAPNETZ STIFTUNG, Hannover, Germany (M.W. Pletz, J. Rupp, G. Rohde); University of Lübeck, Lübeck, Germany (J. Rupp); Maastricht University Medical Centre, Maastricht, the Netherlands (G. Rohde)
Figure 1. Results of molecular detection of Mycoplasma pneumoniae from 783 respiratory tract specimens from adult patients with pneumonia, Germany, March 2011–December 2012. A) Quarterly incidence of M. pneumoniae infection. n values indicate number of samples investigated by real-time PCR. B) M. pneumoniae P1 genotypes. C) M. pneumoniae multilocus variable-number tandem-repeat analysis types. Numbers of strains belonging to a given type are indicated in parentheses.
Page created: February 18, 2015
Page updated: February 18, 2015
Page reviewed: February 18, 2015
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.